Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.1B | 5.8B | 5.4B | 4.9B |
Cost of revenue | 2.5B | 2.8B | 2.7B | 2.2B |
Gross profit | 3.6B | 2.9B | 2.7B | 2.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 513.6M | 498.3M | 433.8M | 334.4M |
Operating income | 1.7B | 1.0B | 913.3M | 913.7M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 12.9M | 10.4M | 24.2M | 10.5M |
Other income expense | — | — | — | — |
Pretax income | 1.9B | 1.4B | 1.1B | 1.1B |
Tax provision | 534.2M | 346.8M | 287.8M | 245.4M |
Net income | 1.4B | 1.1B | 825M | 904.4M |
Basic EPS | — | 2.1 | 1.5 | 1.6 |
Diluted EPS | — | 2.1 | 1.5 | 1.6 |
Basic average shares | — | 481.2M | 480.1M | 480.4M |
Diluted average shares | — | 481.2M | 480.1M | 480.4M |
EBITDA | 2.1B | 1.6B | 1.3B | 1.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | -86.2M | -93M | -95.2M | -114.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |